Complementary Prognostic Value of Cystatin C, N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin T in Patients With Acute Heart Failure

American Journal of Cardiology

Volumn 103, Issue 12, 2009, Pages 1753-1759

  Manzano Fernández, Sergio ^a   Boronat Garcia, Miguel ^a   Albaladejo Otón, María Dolores ^a   Pastor, Patricia ^a   Garrido, Iris Paula ^a   Pastor Pérez, Francisco Jose ^a   Martínez Hernández, Pedro ^a   Valdés, Mariano ^a   Pascual Figal, Domingo Andres ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; TROPONIN T;

ACCURACY; ACUTE HEART FAILURE; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CLINICAL ASSESSMENT; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MORTALITY; PHYSICIAN; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REGISTER; STRATIFICATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; CYSTATIN C; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RISK FACTORS; SPAIN; TROPONIN T;

EID: 67649394229     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.02.029     Document Type: Article

References (22)

1. Nieminen M.S., Bohm M., Cowie M.R., Drexler H., Filippatos G.S., Jondeau G., Hasin Y., Lopez-Sendon J., Mebazaa A., Metra M., Rhodes A., Swedberg K., Priori S.G., Garcia M.A., Blanc J.J., Budaj A., Cowie M.R., Dean V., Deckers J., Burgos E.F., Lekakis J., Lindahl B., Mazzotta G., Morais J., Oto A., Smiseth O.A., Garcia M.A., Dickstein K., Albuquerque A., Conthe P., Crespo-Leiro M., Ferrari R., Follath F., Gavazzi A., Janssens U., Komajda M., Morais J., Moreno R., Singer M., Singh S., Tendera M., Thygesen K., and ESC Committee for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
2. Pascual-Figal D.A., Manzano-Fernandez S., Pastor F., Garrido I.P., Casas T., Sanchez M.J., Ansaldo P., Martinez P., and Valdes M. Troponin T monitoring in outpatients with nonischemic heart failure. Rev Esp Cardiol 61 (2008) 678-686
3. Perna E.R., Macin S.M., Cimbaro Canella J.P., Alvarenga P.M., Rios N.G., Pantich R., Augier N., Farias E.F., Jantus E., Brizuela M., and Medina F. Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. Int J Cardiol 99 (2005) 253-261
4. Setsuta K., Seino Y., Takahashi N., Ogawa T., Sasaki K., Harada A., Takano T., Kishida H., and Hayakawa H. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 84 (1999) 608-611
5. Harrison A., Morrison L.K., Krishnaswamy P., Kazanegra R., Clopton P., Dao Q., Hlavin P., and Maisel A.S. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 39 (2002) 131-138
6. Januzzi J.L., van K.R., Lainchbury J., Bayes-Genis A., Ordonez-Llanos J., Santalo-Bel M., Pinto Y.M., and Richards M. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the international collaborative of NT-proBNP study. Eur Heart J 27 (2006) 330-337
7. van Kimmenade R.R., Pinto Y.M., Bayes-Genis A., Lainchbury J.G., Richards A.M., and Januzzi Jr. J.L. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure. Am J Cardiol 98 (2006) 386-390
8. Ishii J., Nomura M., Nakamura Y., Naruse H., Mori Y., Ishikawa T., Ando T., Kurokawa H., Kondo T., Nagamura Y., Ezaki K., and Hishida H. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 89 (2002) 691-695
9. Taniguchi R., Sato Y., Yamada T., Ooba M., Higuchi H., Matsumori A., Kimura T., and Kita T. Combined measurements of cardiac troponin T and N-terminal pro-brain natriuretic peptide in patients with heart failure. Circ J 68 (2004) 1160-1164
10. World Health Organization. Nutritional Anemias: Report of a WHO Scientific Group (1968), World Health Organization, Geneva, Switzerland
11. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D., and Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130 (1999) 461-470
12. Shlipak M.G., Katz R., Fried L.F., Jenny N.S., Stehman-Breen C.O., Newman A.B., Siscovick D., Psaty B.M., and Sarnak M.J. Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol 45 (2005) 268-271
13. Arimoto T., Takeishi Y., Niizeki T., Takabatake N., Okuyama H., Fukui A., Tachibana H., Nozaki N., Hirono O., Tsunoda Y., Miyashita T., Shishido T., Takahashi H., Koyama Y., and Kubota I. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure. J Card Fail 11 (2005) 595-601
14. Tang W.H., Van L.F., Shrestha K., Troughton R.W., Francis G.S., Tong W., Martin M.G., Borowski A.G., Jasper S., Starling R.C., and Klein A.L. Impact of myocardial function on cystatin C measurements in chronic systolic heart failure. J Card Fail 14 (2008) 394-399
15. Lassus J., Harjola V.P., Sund R., Siirila-Waris K., Melin J., Peuhkurinen K., Pulkki K., and Nieminen M.S. Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur Heart J 28 (2007) 1841-1847
16. Forman D.E., Butler J., Wang Y., Abraham W.T., O'Connor C.M., Gottlieb S.S., Loh E., Massie B.M., Rich M.W., Stevenson L.W., Young J.B., and Krumholz H.M. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43 (2004) 61-67
17. McAlister F.A., Ezekowitz J., Tonelli M., and Armstrong P.W. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109 (2004) 1004-1009 March 2
18. Siirila-Waris K., Lassus J., Melin J., Peuhkurinen K., Nieminen M.S., and Harjola V.P. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J 27 (2006) 3011-3017
19. Fricker M., Wiesli P., Brandle M., Schwegler B., and Schmid C. Impact of thyroid dysfunction on serum cystatin C. Kidney Int 63 (2003) 1944-1947
20. Knight E.L., Verhave J.C., Spiegelman D., Hillege H.L., De Z.D., Curhan G.C., and de Jong P.E. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65 (2004) 1416-1421
21. Bokenkamp A., van Wijk J.A., Lentze M.J., and Stoffel-Wagner B. Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations. Clin Chem 48 (2002) 1123-1126
22. Shlipak M.G., Sarnak M.J., Katz R., Fried L.F., Seliger S.L., Newman A.B., Siscovick D.S., and Stehman-Breen C. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352 (2005) 2049-2060